Dana dhuwit diétung saben saham iterumtx.com (ITRM)

Lambang korporat lan logo Iterum Therapeutics PLC (ITRM)

The cash per share metric demonstrates liquidity dynamics, where the value of 0.00 expresses the level of the metric. Iterum Therapeutics plc (ITRM) is valued by physicians for its development of antibiotics against resistant infections. The scientific team operates under conditions of academic freedom, receiving bonuses for testing milestones. The company is currently transitioning to active sales of its oral drug in the US market following FDA approval.

Dhuwit awis saben siji saham Iterum Therapeutics PLC (ITRM): kanggo periode 04.07.2022 - 11.04.2026

Rincian analitis perusahaan Iterum Therapeutics plc

- rega saiki lan proyeksi nilai saham:
- rincian posisi dhuwit lan arus kas:
Analisis umum perusahaan:ITRM, Iterum Therapeutics PLC
Produk asli Iterum Therapeutics plc

Iterum Therapeutics plc relies on outsourcing antibiotic production, making liquidity control critically important. This cash per share metric is calculated by dividing the total amount of cash by the number of outstanding shares. The metric digitizes the actual reserve of "liquid" cash available for each ownership stake. This chart reflects the company's ability to fund external partners without equity dilution. For the investor, this serves as an indicator of financial stability or developmental stagnation.